This Week’s CGT News: Gene-Editing Trial Death Raises Concerns - Summary - MDSpire

This Week’s CGT News: Gene-Editing Trial Death Raises Concerns

A previously undisclosed death in China raises questions about gene-editing oversight, deramiocel meets its Phase 3 Duchenne endpoint, and researchers identify a source of CAR NK dysfunction

August 3, 2026
5 min

The Medicine Maker

Share

Original Source(s)

The Medicine Maker

This Week’s CGT News: Gene-Editing Trial Death Raises Concerns

August 3, 2026

Related Content

Frontiers In Medicine

Multimodal breast cancer diagnosis using feature fusion and deep learning

Frontiers In Oncology

ORC6 marks a replication-active malignant epithelial state and is associated with immune-low features in oral squamous cell carcinoma

by Shaofu Yan, Wenqi Tan, Yanxin Zhang, Jinyan Si, Jiehua Guo, Bo Yang, Jing Shi
July 21, 2026

Jama Network Open

Racial Differences in Secondary Treatment Pathways and Survival in Localized Prostate Cancer

by Jessica Acolin, Yibai Zhao, Sarah K. Holt, John L. Gore, Ting Martin Ma, Ruth Etzioni, Yaw A. Nyame
July 21, 2026